Computer Science · Artificial Intelligence
In Vitro Activities of Cefepime Alone and with Amikacin against Aminoglycoside-Resistant Gram-Negative Bacteria
Joan Fung Tomc, Elizabeth Huczko, Benjamin Kolek, Christian Thater, Robert, E. Kessler
See on the mapAbstract
The in vitro activity of cefepime was compared with those of ceftazidime, cefotaxime, and cefpfrome against amlnoglycoside..resistaAit gram-negative bacteria. Cefepime was the most active cephalosporin, with a MIC for 90 % of strains tested for all non-Pseudomonas aeruginosa species of c4 txg/mI. No cefepime resistance was encountered among members of the family Enterobacteriaceae. Of the 40 aminoglycoside-resistant P. aeruginosa isolates, 15 % were resistant to cefepime, compared with 18 % for ceftazidime, 30 % for cefpirome, and 35 % for celotaxime. Synersm between cefepime and amikacin was observed and occurred most frequently in P. aeruginosa strains resistant to. cefepime but susceptible to amikacin. In no case did cefepime and amikacin exhibit antagonism against P. aeruginosa. Broad-spectrum cephalosporins and aminoglycosides are highly active against aerobic gram-negative bacteria. How-ever, resistance to these agents has developed during their clinical use. Resistance to the expanded-spectrum cephalo-sporins may result in up to one-half of patients infected with Pseudomonas aeruginosa, Entierobacter spp., or Serratia marcescens during or after therapy and is primarily,the